Ligand id: 9721

Name: cipargamin

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 0
Topological polar surface area 56.92
Molecular weight 389.05
XLogP 3.58
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Compound class Synthetic organic
Ligand families/groups Antimalarial ligands
International Nonproprietary Names
INN number INN
9865 cipargamin
KAE609 | NITD609
Cipargamin is an antimalarial drug candidate, under clinical development. It is the optimised lead for the spiroindolones, a novel class of compounds identified from a phenotypic screen as having antimalarial activity [2,7] and awarded MMV Project of the Year (2009).
The active enantiomer is shown here, with the 1R,3S configuration essential for antimalarial activity [2].
Cipargamin has potent activity against the asexual blood stages of P. falciparum and P. vivax [2] and potential as a transmission blocking therapy with a study reporting that the drug inhibits gametocytogenesis and blocks P. falciparum transmission to the Anopheles mosquito vector [5].

Potential Target/Mechanism Of Action: A number of studies have investigated the mechanism of action of cipargamin, with evidence from genetic experiments indicating Plasmodium non-SERCA-type Ca2+-transporting P-ATPase (PfATP4) may be the target [1-2].
Database Links
CAS Registry No. 1193314-23-6 (source: Scifinder)
ChEMBL Ligand CHEMBL1082723
GtoPdb PubChem SID 374883822
PubChem CID 44469321
Search Google for chemical match using the InChIKey CKLPLPZSUQEDRT-WPCRTTGESA-N
Search Google for chemicals with the same backbone CKLPLPZSUQEDRT
Search PubMed clinical trials cipargamin
Search PubMed titles cipargamin
Search PubMed titles/abstracts cipargamin
Search UniChem for chemical match using the InChIKey CKLPLPZSUQEDRT-WPCRTTGESA-N
Search UniChem for chemicals with the same backbone CKLPLPZSUQEDRT
Wikipedia Cipargamin